Characteristic | Healthy control (n = 628) | PRISm (n = 126) | Spirometry-defined COPD (n = 685) |
---|---|---|---|
Before bronchodilator use | Â | Â | Â |
FEV1, L | 2.49 ± 0.53 | 1.82 ± 0.42* | 1.85 ± 0.62 |
FEV1% of predicted, % | 93.7 ± 11.2 | 70.7 ± 8.8* | 68.6 ± 19.6 |
FVC, L | 3.27 ± 0.72 | 2.44 ± 0.58*†| 3.24 ± 0.80 |
FVC% of predicted, % | 98.3 ± 12.0 | 75.2 ± 10.4*†| 94.6 ± 18.7 |
FVC < 80%predicted, n (%) | 38 (6.1) | 89 (70.6)*†| 153 (22.3) |
FEV1/FVC, % | 76.6 ± 6.3 | 74.9 ± 5.9†| 56.4 ± 10.2 |
After bronchodilator use | Â | Â | Â |
FEV1, L | 2.57 ± 0.52 | 1.85 ± 0.38* | 1.97 ± 0.61 |
FEV1% of predicted, % | 96.7 ± 10.5 | 72.2 ± 6.8* | 72.9 ± 19.0 |
FVC, L | 3.26 ± 0.70 | 2.40 ± 0.53*†| 3.36 ± 0.78 |
FVC% of predicted, % | 97.9 ± 11.2 | 74.0 ± 8.4*†| 98.0 ± 17.7 |
FVC < 80% predicted, n (%) | 24(3.8) | 91(72.2)*†| 102 (14.9) |
FEV1/FVC, % | 79.3 ± 5.6 | 77.6 ± 5.8†| 58.0 ± 9.7 |
Airflow reversibility, n (%) | 33 (5.3) | 9 (7.1)†| 122 (17.8) |